NCT06897761

Brief Summary

Our study aims to develop a personalized interactive digital breathing game and device that can be produced in our country and to provide daily airway cleaning treatment at home via mobile phone or computer without the need for a physiotherapist or healthcare professional with the use of an interactive digital breathing game.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2024

Completed
6 months until next milestone

First Posted

Study publicly available on registry

March 27, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

October 7, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

January 6, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

September 18, 2024

Last Update Submit

January 2, 2026

Conditions

Keywords

respiratory game, Active Cycle of Breathing Techniquesbronchiectasis

Outcome Measures

Primary Outcomes (3)

  • 6 Minute Walk Test

    6MWT is defined as a submaximal test that can be easily applied in healthy or unhealthy individuals and is evaluated as an indicator of exercise capacity and walking capacity as well as many cardiovascular diseases. The 6MWT is referred to as the "Gold Standard" test of walking capacity. The aim of this test is to reach the longest possible walking distance at the end of six minutes. The standard protocol is applied in a 30-meter uninterrupted corridor or open area. It is recommended to repeat the 6MWT three times on the same day with a one-hour rest interval; the maximum walking distance is taken into account.

    baseline and within 1 week after intervention

  • Evaluation of Expiratory Muscle Strength

    Inspiratory and expiratory respiratory muscle strength will be evaluated by measuring maximal mouth pressure. Maximal mouth pressure will be measured using the Micro RPM brand (Micro Medical; England) portable electronic mouth pressure measurement device, in accordance with ATS/ERS criteria. Maximal expiratory pressure (MEP) will be measured to assess expiratory muscle strength.

    baseline and within 1 week after intervention

  • Evaluation of Inspiratory Muscle Strength

    Inspiratory and expiratory respiratory muscle strength will be evaluated by measuring maximal mouth pressure. Maximal mouth pressure will be measured using the Micro RPM brand (Micro Medical; England) portable electronic mouth pressure measurement device, in accordance with ATS/ERS criteria. Maximal inspiratory pressure (MIP) will be measured to assess inspiratory muscle strength,.

    baseline and within 1 week after intervention

Secondary Outcomes (8)

  • Evaluation of Quality of Life

    baseline and within 1 week after intervention

  • Evaluation of Cough

    baseline and within 1 week after intervention

  • Assessment of Sleep Quality

    baseline and within 1 week after intervention

  • Evaluation of Peripheral Muscle Strength

    baseline and within 1 week after intervention

  • Respiratory Function Test- FEV1 value

    baseline and within 1 week after intervention

  • +3 more secondary outcomes

Other Outcomes (1)

  • Evaluation of Participation in the Program

    baseline and within 1 week after intervention

Study Arms (2)

Breathing Game Group

EXPERIMENTAL

The participants will perform the interactive digital game.

Device: Interactive Digital Respiratory GameOther: home-based exercise training

Control Group

ACTIVE COMPARATOR

The participants will perform home based exercise

Other: home-based exercise training

Interventions

Patients in the home-based exercise training group will be asked to perform the active breathing techniques cycle, which is an airway clearance technique, twice a day, 7 days a week, for 20 minutes each, for 8 weeks and to follow the program that includes physical activity recommendations. Patients who use mucolytic and/or nebulized drugs such as hypertonic saline or mannitol will be instructed to perform nebulization before performing the active breathing techniques cycle.

Also known as: chest physiotherapy
Breathing Game GroupControl Group

With the development of technology and digitalization, Digital Respiratory Games (DRG) offer an alternative solution. DRGs, with their difficulty levels, provide a platform for progression, offering a fun and engaging experience that enhances patient adherence to therapy through storytelling and user interaction. The absence of a locally made DRG in Turkey, despite the chronic respiratory diseases impact, has led to the need for an interactive DRG with personalized features. The developed interactive DRG and device will be Turkey first interactive DRG example, designed to respond to different respiratory maneuvers. The developed DRG and device will detect the lung volume and flow rates and allow for the real-time execution of maneuvers within the Active Cycle of Breathing Techniques (ACBT) in a playful environment.

Breathing Game Group

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged between 7-18 years
  • Clinically stable
  • No exacerbations or infections
  • Possesses a computer, tablet, or mobile phone

You may not qualify if:

  • Participation in a supervised physiotherapy and rehabilitation program within the last 6 months
  • History of lung or liver transplant
  • Presence of any cognitive impairment that would hinder the use of the system
  • Changes in medical treatment during the study
  • Presence of concurrent cardiac, orthopedic, or neurological diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Atlas University

Istanbul, 34000, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Bronchiectasis

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

September 18, 2024

First Posted

March 27, 2025

Study Start

October 7, 2025

Primary Completion

December 7, 2025

Study Completion

January 15, 2026

Last Updated

January 6, 2026

Record last verified: 2026-01

Locations